Groundbreaking NanoCept® Innovation Center Elevates Orthopaedic Safety

Groundbreaking NanoCept® Innovation Center Elevates Orthopaedic Safety

Groundbreaking NanoCept® Innovation Center Elevates Orthopaedic Safety

Tech Dec 13, 2025

In an impressive move set to redefine the standards in orthopedic procedures, Onkos Surgical has unveiled its brand new NanoCept Innovation Center in Bridgewater, NJ. The unveiling of this cutting-edge facility on the New Jersey Center of Excellence Campus reflects a bold stride in the surgical realm, one dedicated to battling bacteria where it matters the most: on the surfaces of orthopedic implants.

Pioneering Antibacterial Technology

The NanoCept® Antibacterial Technology stands as the first commercially available antimicrobial coating in the U.S., aimed to proactively counter the threats of intraoperative bacterial contamination. The creation of this technology is not just an incremental step; it truly transforms how surgical implant safety is perceived and practiced.

According to Ortho Spine News, the arrival of the NanoCept® Innovation Center is poised to revolutionize the market, offering increased production capabilities to meet heightened demand. This is indeed a trailblazing move in the field of orthopedic implants and a testament to Onkos Surgical’s commitment to innovation and healthcare advancement.

Expanding Capacities and Commitment

The new 4,600-square-foot facility is not just about innovation; it is about a commitment to excellence. By bringing the full innovation cycle in-house, Onkos aims to provide rapid solutions to surgeons—enhancing patient outcomes through this novel technology.

Adding yet another feather to its cap, Onkos’ expansion in New Jersey represents a strong endorsement of its regional commitment. Apart from fueling local employment with positions for chemists, engineers, and technicians, the center underscores Onkos’s dedication to fostering an ecosystem where cutting-edge innovation can thrive.

Leading Voices Give Their Resounding Support

Patrick Treacy, Founder and CEO of Onkos Surgical, elucidated, “This investment will allow us to get this groundbreaking technology into the hands of more surgeons, faster, and it puts us in a position to help more patients with complex orthopedic conditions.” Dr. Steven Gitelis echoed this sentiment, expressing excitement about the new possibilities this technology avails to surgeons worldwide.

A New Milestone in the Making

As the official ribbon-cutting ceremony unfolded, key stakeholders including township council members, government officials, and notable guests from the medical community praised Onkos Surgical for this transformative step. “Delivering meaningful advancements in patient care defines our district, and Onkos Surgical exemplifies this spirit,” noted Congressman Tom Kean, Jr.

The realization of the NanoCept® Innovation Center marks a significant milestone on Onkos Surgical’s journey. It’s like uncovering a new chapter in modern medicine—a chapter where innovation meets practicality, offering solutions that not only anticipate but effectively address one of the most pressing challenges in surgical procedures today.

The center is now set to lead the charge in delivering safer, more reliable orthopedic solutions to surgeons and patients alike. Here’s to a future where medical technology closes the gap between possibilities and procedures—making the operating room not only a place of healing but a fortress against infections.

Tags